Related Experiment Video
Updated: Jan 17, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
The Pyrimidinyl Hydrazones: Selective for anti-Cancer cytotoxicity
Rohina Alim1, Scott D Andrew1, Christopher J Parkinson1
1School of Dentistry and Medical Sciences, Charles Sturt University, NSW 2800, Australia.
None:
Pyrimidinyl hydrazones (PH) can be prepared using simple procedures beginning with dichloropyrimidine. A total of 9 PH were synthesised and these compounds associated strongly with copper, iron and zinc ions both at physiological and mildly acidic pH. The PH were cytotoxic in vitro against cancer cell lines (compound 15 having IC50 values of 0.37, 0.11 and 1.09 μM against melanoma, ovarian cancer and pancreatic cancer cell lines respectively - these values being superior to known agents such as doxorubicin) and displayed only minimal toxicity against non-cancer cell lines (no toxicity at 25 μM against the non-cancer MRC-5 fibroblast). Copper complexes of the PH formed in situ showed cytotoxicity against cancer lines similar to that of the PH alone - albeit with substantial increases in toxicity against non-cancer cells. Association of PH with iron or zinc ions in situ did not generally result in enhanced potency - unlike related thiosemicarbazones. The cytotoxic potency of PH was comparable to that observed for thiosemicarbazones. The PH are likely to exert their cytotoxic action through a combination of metal mobilisation and reactive oxygen generation. The PH should be more extensively studied as a class of metal-chelating anti-cancer agents.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Inhibition of Cdk Activity
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Treatment Resistant Cancers

